Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Determination of the CCR5∆32 frequency in Emiratis and Tunisians and the screening of the CCR5 gene for novel alleles in Emiratis.

Al-Jaberi SA, Ben-Salem S, Messedi M, Ayadi F, Al-Gazali L, Ali BR.

Gene. 2013 Oct 15;529(1):113-8. doi: 10.1016/j.gene.2013.07.062. Epub 2013 Aug 9.

PMID:
23933274
[PubMed - indexed for MEDLINE]
2.

Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.

Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA.

J Clin Virol. 2005 Dec;34(4):310-4.

PMID:
16286055
[PubMed - indexed for MEDLINE]
3.

Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders.

Lu Y, Nerurkar VR, Dashwood WM, Woodward CL, Ablan S, Shikuma CM, Grandinetti A, Chang H, Nguyen HT, Wu Z, Yamamura Y, Boto WO, Merriwether A, Kurata T, Detels R, Yanagihara R.

Int J Infect Dis. 1999 Summer;3(4):186-91.

PMID:
10575146
[PubMed - indexed for MEDLINE]
4.

Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.

Nkenfou CN, Mekue LC, Nana CT, Kuiate JR.

BMC Res Notes. 2013 Jul 23;6:288. doi: 10.1186/1756-0500-6-288.

PMID:
23880174
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.

Jlizi A, Edouard J, Fadhlaoui-Zid K, Frigi S, Debré P, Slim A, Theodorou I, El Gaaied AB, Carpentier W.

Hum Immunol. 2007 Dec;68(12):993-1000. doi: 10.1016/j.humimm.2007.10.003. Epub 2007 Oct 30.

PMID:
18191728
[PubMed - indexed for MEDLINE]
6.

Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.

Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, Lam G, Vaccarezza M, Kennedy PE, Kumaraswami V, Giorgi JV, Detels R, Hunter J, Chopek M, Berger EA, Fauci AS, Nutman TB, Murphy PM.

Mol Med. 1997 Jan;3(1):23-36.

PMID:
9132277
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.

Sharda S, Gilmour A, Harris V, Singh VP, Sinha N, Tewari S, Ramesh V, Agrawal S, Mastana S.

Int J Cardiol. 2008 Feb 29;124(2):254-8. Epub 2007 Mar 26.

PMID:
17383752
[PubMed - indexed for MEDLINE]
8.

Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.

Wang FS, Hong WG, Cao Y, Liu MX, Jin L, Hu LP, Wang Z, Feng TJ, Hou J, Zhang B, Shi M, Xu DP, Lei ZY, Wang B, Liu ZD, Ye JJ, Peng L, Qiu Y, Winkler C.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):124-30.

PMID:
12571520
[PubMed - indexed for MEDLINE]
9.

Distribution of the CCR5 gene 32-basepair deletion in 11 Chinese populations.

Zhang C, Fu S, Xue Y, Wang Q, Huang X, Wang B, Liu A, Ma L, Yu Y, Shi R, Lv F, Shi Z, Zhang Y, Cheng W, Ai Q, Xu F, Huang C, Chen B, Kang X, Sun Y, Zhang G, Li P.

Anthropol Anz. 2002 Sep;60(3):267-71.

PMID:
12378793
[PubMed - indexed for MEDLINE]
10.

A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.

Kostrikis LG, Neumann AU, Thomson B, Korber BT, McHardy P, Karanicolas R, Deutsch L, Huang Y, Lew JF, McIntosh K, Pollack H, Borkowsky W, Spiegel HM, Palumbo P, Oleske J, Bardeguez A, Luzuriaga K, Sullivan J, Wolinsky SM, Koup RA, Ho DD, Moore JP.

J Virol. 1999 Dec;73(12):10264-71.

PMID:
10559343
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.

Li C, Yan YP, Shieh B, Lee CM, Lin RY, Chen YM.

J Formos Med Assoc. 1997 Dec;96(12):979-84.

PMID:
9444918
[PubMed - indexed for MEDLINE]
12.

Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.

Reiche EM, Ehara Watanabe MA, Bonametti AM, Morimoto HK, Akira Morimoto A, Wiechmann SL, Matsuo T, Carvalho De Oliveira J, Vissoci Reiche F.

Int J Mol Med. 2008 Nov;22(5):669-75.

PMID:
18949389
[PubMed - indexed for MEDLINE]
13.

[Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].

Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M.

Wiad Lek. 2005;58(9-10):500-7. Polish.

PMID:
16529059
[PubMed - indexed for MEDLINE]
14.

The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe.

Libert F, Cochaux P, Beckman G, Samson M, Aksenova M, Cao A, Czeizel A, Claustres M, de la Rúa C, Ferrari M, Ferrec C, Glover G, Grinde B, Güran S, Kucinskas V, Lavinha J, Mercier B, Ogur G, Peltonen L, Rosatelli C, Schwartz M, Spitsyn V, Timar L, Beckman L, Parmentier M, Vassart G.

Hum Mol Genet. 1998 Mar;7(3):399-406.

PMID:
9466996
[PubMed - indexed for MEDLINE]
Free Article
15.

Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.

Salem AH, Farid E, Fadel R, Abu-Hijleh M, Almawi W, Han K, Batzer MA.

AIDS Res Hum Retroviruses. 2009 Oct;25(10):973-7. doi: 10.1089/aid.2009.0066.

PMID:
19803715
[PubMed - indexed for MEDLINE]
16.

CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).

McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM.

Lancet. 1998 Sep 12;352(9131):866-70.

PMID:
9742978
[PubMed - indexed for MEDLINE]
17.

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ.

Gastroenterology. 2003 Feb;124(2):352-60. Erratum in: Gastroenterology. 2003 Apr;124(4):1168..

PMID:
12557141
[PubMed - indexed for MEDLINE]
18.

Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India.

Ramana GV, Vasanthi A, Khaja M, Su B, Govindaiah V, Jin L, Singh L, Chakraborty R.

J Genet. 2001 Dec;80(3):137-40.

PMID:
11988632
[PubMed - indexed for MEDLINE]
Free Article
19.

CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.

Clegg AO, Ashton LJ, Biti RA, Badhwar P, Williamson P, Kaldor JM, Stewart GJ.

AIDS. 2000 Jan 28;14(2):103-8.

PMID:
10708279
[PubMed - indexed for MEDLINE]
20.

32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.

Kamkamidze G, Capoulade-Metay C, Butsashvili M, Dudoit Y, Chubinishvili O, Debre P, Theodorou L.

Georgian Med News. 2005 Jan;(118):74-9.

PMID:
15821335
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk